Last updated at 26 Feb 2025 04:13 PM
Director
DIN: 10074281
Pushkar Digambar Zawar is currently associated with 2 companies as Director. They serve as a Director at IMPULSE PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10074281.Pushkar Digambar Zawar has previously been associated with 1 company in roles such as Additional Director.Pushkar Digambar Zawar is currently involved in 1 different role. Their most recent position is with KITEMARK LIFESCIENCES PRIVATE LIMITED as a Director. The first company Pushkar Digambar Zawar was appointed to as a director was IMPULSE PHARMA PRIVATE LIMITED. Pushkar Digambar Zawar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Pushkar Digambar Zawar is currently associated with 2 companies as Director. They serve as a Director at IMPULSE PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 10074281.Pushkar Digambar Zawar has previously been associated with 1 company in roles such as Additional Director.Pushkar Digambar Zawar is currently involved in 1 different role. Their most recent position is with KITEMARK LIFESCIENCES PRIVATE LIMITED as a Director. The first company Pushkar Digambar Zawar was appointed to as a director was IMPULSE PHARMA PRIVATE LIMITED. Pushkar Digambar Zawar is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (1)
7 Months 4 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| IMPULSE PHARMA PRIVATE LIMITED | Director | 30-Sep-2023 |
| KITEMARK LIFESCIENCES PRIVATE LIMITED | Director | 20-Feb-2025 |